DE602006003818D1 - Pharmazeutische Zusammensetzung zur perkutane Absorption unter Verwendung von einem Metalchlorid, vorzugsweise Natriumchlorid, zur Vorbeugung von Kohäsionsschwäche - Google Patents

Pharmazeutische Zusammensetzung zur perkutane Absorption unter Verwendung von einem Metalchlorid, vorzugsweise Natriumchlorid, zur Vorbeugung von Kohäsionsschwäche

Info

Publication number
DE602006003818D1
DE602006003818D1 DE602006003818T DE602006003818T DE602006003818D1 DE 602006003818 D1 DE602006003818 D1 DE 602006003818D1 DE 602006003818 T DE602006003818 T DE 602006003818T DE 602006003818 T DE602006003818 T DE 602006003818T DE 602006003818 D1 DE602006003818 D1 DE 602006003818D1
Authority
DE
Germany
Prior art keywords
percutaneous absorption
cohesive
selegiline
weakness
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006003818T
Other languages
English (en)
Inventor
Keigo Inosaka
Junichi Sekiya
Akio Takada
Toshinobu Tsuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Denko Corp
Original Assignee
Nitto Denko Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37056495&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602006003818(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nitto Denko Corp filed Critical Nitto Denko Corp
Publication of DE602006003818D1 publication Critical patent/DE602006003818D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602006003818T 2005-06-06 2006-05-31 Pharmazeutische Zusammensetzung zur perkutane Absorption unter Verwendung von einem Metalchlorid, vorzugsweise Natriumchlorid, zur Vorbeugung von Kohäsionsschwäche Active DE602006003818D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005165213 2005-06-06

Publications (1)

Publication Number Publication Date
DE602006003818D1 true DE602006003818D1 (de) 2009-01-08

Family

ID=37056495

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006003818T Active DE602006003818D1 (de) 2005-06-06 2006-05-31 Pharmazeutische Zusammensetzung zur perkutane Absorption unter Verwendung von einem Metalchlorid, vorzugsweise Natriumchlorid, zur Vorbeugung von Kohäsionsschwäche

Country Status (9)

Country Link
US (1) US8409609B2 (de)
EP (1) EP1733719B2 (de)
KR (1) KR20060127779A (de)
CN (1) CN1875953B (de)
AT (1) ATE415154T1 (de)
CA (1) CA2548864C (de)
DE (1) DE602006003818D1 (de)
IL (1) IL176032A0 (de)
RU (1) RU2432179C2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2452474C2 (ru) * 2006-12-01 2012-06-10 Нитто Денко Корпорейшн Стабилизированная адгезивная композиция, содержащая донепезил
WO2008066185A1 (fr) * 2006-12-01 2008-06-05 Nitto Denko Corporation Procédé destiné à prévenir la décoloration provoquée par le temps d'une préparation d'adhésif cutané contenant du donépézil
CA2725484A1 (en) * 2008-05-30 2009-12-03 Eisai R&D Management Co., Ltd. Percutaneously absorbable preparation
KR101558454B1 (ko) * 2013-11-18 2015-10-06 조선대학교산학협력단 셀레질린 또는 그의 약학적으로 허용가능한 염을 함유하는 경피흡수제제
RU2762896C2 (ru) 2016-12-20 2021-12-23 Лтс Ломанн Терапи-Систем Аг Трансдермальная терапевтическая система, содержащая азенапин
AU2017384392B2 (en) 2016-12-20 2023-05-25 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
CN110799180A (zh) 2017-06-26 2020-02-14 罗曼治疗***股份公司 含阿塞那平和硅氧烷丙烯酸杂化聚合物的经皮治疗***
CN112704672A (zh) 2018-06-20 2021-04-27 罗曼治疗***股份公司 含有阿塞那平的透皮治疗***

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322400A (en) 1978-12-19 1982-03-30 Dragoco Inc. Cosmetic stick composition
US4407897A (en) * 1979-12-10 1983-10-04 American Can Company Drying agent in multi-layer polymeric structure
JPH0757863B2 (ja) 1987-12-29 1995-06-21 日本合成化学工業株式会社 感圧性接着剤組成物
EP0435199B2 (de) 1989-12-28 2000-01-19 Nitto Denko Corporation Acrylgel und seine Herstellung
JP3046346B2 (ja) * 1990-03-12 2000-05-29 昭和電工株式会社 外用剤基剤又は補助剤とそれを含有する人又は動物の外用剤
KR920703033A (ko) * 1990-11-09 1992-12-17 아카자와 소조 프로카테롤을 함유한 외용제
US5462746A (en) * 1992-11-02 1995-10-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
CA2117546A1 (en) * 1993-08-27 1995-02-28 Takateru Muraoka Medical adhesive sheet
US5399362A (en) * 1994-04-25 1995-03-21 Edward Mendell Co., Inc. Once-a-day metoprolol oral dosage form
JP3831423B2 (ja) 1995-04-25 2006-10-11 積水化学工業株式会社 貼付剤
CA2223588C (en) * 1995-06-07 2004-01-06 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
US20040062759A1 (en) * 1995-07-12 2004-04-01 Cygnus, Inc. Hydrogel formulations for use in electroosmotic extraction and detection of glucose
JP3361674B2 (ja) † 1995-11-08 2003-01-07 日本カーバイド工業株式会社 医療用粘着剤組成物
US6121508A (en) * 1995-12-29 2000-09-19 3M Innovative Properties Company Polar, lipophilic pressure-sensitive adhesive compositions and medical devices using same
US5645855A (en) * 1996-03-13 1997-07-08 Ridge Scientific Enterprises, Inc. Adhesive compositions including polyvinylpyrrolidone acrylic acid polymers, and polyamines
JPH09315976A (ja) 1996-05-29 1997-12-09 Nitto Denko Corp 経皮投与用製剤
FR2749586B1 (fr) 1996-06-11 1998-08-07 Hoechst Marion Roussel Inc Nouveaux dispositifs destines a l'administration transdermique de la trimegestone, leur procede de preparation et leur application a titre de medicaments
JP2001501913A (ja) 1996-06-28 2001-02-13 ユニリーバー・ナームローゼ・ベンノートシヤープ 液体制汗／防臭組成物
US5922308A (en) 1996-06-28 1999-07-13 Chesebrough-Pond's Usa Co., Underarm compositions
US7150881B2 (en) * 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
JPH11209270A (ja) 1998-01-22 1999-08-03 Nitto Denko Corp 経皮吸収製剤
JPH11209271A (ja) 1998-01-23 1999-08-03 Nitto Denko Corp 経皮吸収製剤
US6146656A (en) † 1998-01-22 2000-11-14 Nitto Denko Corporation Percutaneous absorption preparation
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
DE60012396T2 (de) † 1999-04-13 2005-07-21 Nitto Denko Corp., Ibaraki Perkutan absorbierbare Zubereitung
JP4378028B2 (ja) 1999-04-13 2009-12-02 日東電工株式会社 経皮吸収型製剤
WO2001043775A2 (en) * 1999-12-16 2001-06-21 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers
JP2001181591A (ja) 1999-12-28 2001-07-03 Nitto Denko Corp ブロック共重合体粘着剤及びこれを用いた医療用粘着テープ、経皮吸収製剤並びにブロック共重合体粘着剤の製造方法
JP4614410B2 (ja) † 2001-03-02 2011-01-19 日東電工株式会社 粘着型光学フィルムおよび光学フィルム用粘着剤
JP5021124B2 (ja) 2001-08-29 2012-09-05 日東電工株式会社 医療用粘着組成物、それを用いた医療用粘着テープおよび経皮吸収用テープ製剤
JP2004010252A (ja) 2002-06-06 2004-01-15 Cleanup Corp 配車運行計画管理システムおよび方法
US7557230B2 (en) * 2005-06-06 2009-07-07 Sony Corporation Latent curing agent

Also Published As

Publication number Publication date
RU2006119610A (ru) 2007-12-20
CA2548864C (en) 2012-12-11
EP1733719B2 (de) 2012-01-04
US20060275354A1 (en) 2006-12-07
CN1875953B (zh) 2011-04-20
KR20060127779A (ko) 2006-12-13
EP1733719A1 (de) 2006-12-20
CA2548864A1 (en) 2006-12-06
EP1733719B1 (de) 2008-11-26
IL176032A0 (en) 2006-10-05
US8409609B2 (en) 2013-04-02
RU2432179C2 (ru) 2011-10-27
ATE415154T1 (de) 2008-12-15
CN1875953A (zh) 2006-12-13

Similar Documents

Publication Publication Date Title
ATE415153T1 (de) Pharmazeutische zusammensetzung zur perkutane absorption unter verwendung von einem metalchlorid, vorzugsweise natriumchlorid, zur vorbeugung von kohäsionsschwäche
DE602006003818D1 (de) Pharmazeutische Zusammensetzung zur perkutane Absorption unter Verwendung von einem Metalchlorid, vorzugsweise Natriumchlorid, zur Vorbeugung von Kohäsionsschwäche
DE60321386D1 (de) Pharmazeutische zubereitung zur modifizierten freisetzung
WO2007062078A3 (en) Thrombopoietin activity modulating compounds and methods
PL374852A1 (en) Hot melt tts for administering rotigotine
DE602005010812D1 (de) Transdermales Pflaster enthaltend einen schmelzpunktsenkenden Hilfsstoff
DK0674913T3 (da) Ikke-okklusivt klæbende plaster til påföring af medicament i huden
WO2009134057A3 (ko) 안지오텐신-ⅱ-수용체 차단제를 포함하는 약제학적 제제
TN2009000317A1 (en) Solid preparation comprising alogliptin and pioglitazone
CL2009000967A1 (es) Compuesto 4-ciclobutil-n-((2s,5r)-5-hidroxi-2-adamantil)-2-morfolin-4-ilpiridin-5-carboxamida, inhibidor de la enzima 11betahsd1; composicion farmaceutica que lo comprende; y su uso en un procedimiento de tratamiento profilactico o terapeutico de un animal de sangre caliente.
WO2005079851A3 (en) Dopamine-agonist combination therapy with sedatives for improving sleep quality
ATE468332T1 (de) Phenyl-(4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin- - yi)aminderivate
WO2008108286A1 (ja) 経皮吸収医薬組成物、医薬組成物貯蔵ユニットおよびこれを利用する経皮吸収製剤
MX2007010900A (es) Sistema terapeutico transdermico no fibroso y metodo para su produccion.
WO2008001200A3 (en) Transdermal composition having enhanced color stability
DE60309963D1 (de) Pharmazeutische Zusammensetzung zur Perkutann Absorption und Verfahren für ihre Herstellung
WO2011029948A3 (de) Transdermales therapeutisches system zur verabreichung von fentanyl oder einem analogstoff davon
WO2008117268A3 (en) A drug delivery device for providing local analgesia, local anesthesia or nerve blockade
AR033748A1 (es) Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
WO2005039486A3 (en) Compounds and compositions as protein kinase inhibitors
AR054012A1 (es) Sistema terapeutico transdermico para la adminstracion de analgesicos
DE502007002949D1 (de) Proteinbindende methotrexat-derivate und diese enthaltende arzneimittel
IL176802A0 (en) Transdermal delivery device for dihydropyridine type calcium antagonists containing at least one fatty acid
JO2492B1 (en) A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
TW200719902A (en) Solid transdermal therapeutic system with uv absorber

Legal Events

Date Code Title Description
8363 Opposition against the patent
R102 Epo decision maintaining patent in amended form now final

Ref document number: 1733719

Country of ref document: EP